US FDA Advisory Committees As The Court Of Appeals

 
• By Michael McCaughan

The US FDA’s use of its advisory committees continues to shrink. In 2022, the expert panels appear primarily to serve as a last chance for sponsors to prevent (or overturn) an FDA rejection.

FDA court of appeals
Is this what advisory committees have become? • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image

More from US FDA Performance Tracker

More from Regulatory Trackers